Technology
Applications
Resources
Support
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Technology
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Technology
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Mutation Profiling
Search All publications
How recent?
Search
Randomized phase II trial of pharmacodynamic separation of pemetrexed and intercalated erlotinib versus pemetrexed alone for advanced non-squamous non-small cell lung cancer
Genomic heterogeneity of multiple synchronous lung cancer
Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma
KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma
The role of CDKN2C copy number in sporadic medullary thyroid carcinoma
Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma
Epidermal Growth Factor Receptor (EGFR) co-mutated advanced non-small cell lung cancer (NSCLC) and response to EGFR tyrosine kinase inhibitors (TKIs): A Brief Report
«
...
10
20
30
...
35
36
37
38
39
...
50
...
»